These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1017 related articles for article (PubMed ID: 34246881)

  • 41. Efficacy and tolerability of anti-epileptic drugs-an internet study.
    Wieshmann UC; Baker G
    Acta Neurol Scand; 2017 May; 135(5):533-539. PubMed ID: 27757951
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee.
    Vossler DG; Bainbridge JL; Boggs JG; Novotny EJ; Loddenkemper T; Faught E; Amengual-Gual M; Fischer SN; Gloss DS; Olson DM; Towne AR; Naritoku D; Welty TE
    Epilepsy Curr; 2020 Sep; 20(5):245-264. PubMed ID: 32822230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of successful valproate withdrawal in women with epilepsy.
    Atalar AÇ; Şirin NG; Bebek N; Baykan B
    Epilepsy Behav; 2021 Jun; 119():107980. PubMed ID: 33957390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Video-EEG evidence of lateralized clinical features in primary generalized epilepsy with tonic-clonic seizures.
    Casaubon L; Pohlmann-Eden B; Khosravani H; Carlen PL; Wennberg R
    Epileptic Disord; 2003 Sep; 5(3):149-56. PubMed ID: 14684350
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Follow-up study on levetiracetam monotherapy in children with epilepsy].
    Gao ZJ; Jiang YW
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Dec; 10(6):711-4. PubMed ID: 19102836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Valproate in adolescents with photosensitive epilepsy with generalized tonic-clonic seizures only.
    Verrotti A; Grosso S; D'Egidio C; Parisi P; Spalice A; Pavone P; Capovilla G; Agostinelli S
    Eur J Paediatr Neurol; 2014 Jan; 18(1):13-8. PubMed ID: 23891468
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tonic-clonic seizures in idiopathic generalized epilepsies: Prevalence, risk factors, and outcome.
    Asadi-Pooya AA; Homayoun M
    Acta Neurol Scand; 2020 Jun; 141(6):445-449. PubMed ID: 32030724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Duration of focal complex, secondarily generalized tonic-clonic, and primarily generalized tonic-clonic seizures--A video-EEG analysis.
    Dobesberger J; Ristić AJ; Walser G; Kuchukhidze G; Unterberger I; Höfler J; Amann E; Trinka E
    Epilepsy Behav; 2015 Aug; 49():111-7. PubMed ID: 25935513
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy.
    Shukla G; Gupta A; Agarwal P; Poornima S
    Epilepsy Behav; 2016 Nov; 64(Pt A):216-218. PubMed ID: 27756024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment outcomes in women with idiopathic generalized epilepsy.
    Kiiski R; Basnyat P; Raitanen J; Rainesalo S; Peltola J; Mäkinen J
    Acta Neurol Scand; 2022 Apr; 145(4):423-433. PubMed ID: 34877648
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Initiating antiepilepsy treatment: An update of expert consensus in Spain.
    Villanueva V; Sánchez-Álvarez JC; Carreño M; Salas-Puig J; Caballero-Martínez F; Gil-Nagel A
    Epilepsy Behav; 2021 Jan; 114(Pt A):107540. PubMed ID: 33243687
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs).
    Stepanova D; Beran RG
    Seizure; 2014 May; 23(5):371-6. PubMed ID: 24630809
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: A retrospective single center study.
    Liguori C; Izzi F; Manfredi N; D'Elia A; Mari L; Mercuri NB; Fabio P
    Epilepsy Behav; 2018 Mar; 80():173-176. PubMed ID: 29414548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003032. PubMed ID: 28195639
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Levetiracetam in toxic seizures.
    Lee T; Warrick BJ; Sarangarm P; Alunday RL; Bussmann S; Smolinske SC; Seifert SA
    Clin Toxicol (Phila); 2018 Mar; 56(3):175-181. PubMed ID: 28753046
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of in utero exposure to valproate or levetiracetam on the seizures and newborn histopathology of genetic absence epilepsy rats.
    Can Kantarci B; Sanli A; Gavas S; Toplu A; Nur Turgan Asik Z; Tugce Cilingir-Kaya O; Gulcebi Idrizoglu M; Ercan F; Onat F
    Neurosci Lett; 2022 Apr; 776():136574. PubMed ID: 35271996
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Encephalopathy induced by levetiracetam added to valproate.
    Bauer J
    Acta Neurol Scand; 2008 May; 117(5):374-6. PubMed ID: 18081909
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk of recurrence in patients with an unprovoked tonic-clonic seizure and generalized epileptiform discharges on EEG.
    Jomaa N; Nasreddine W; Hmeimess G; Beaini S; Beydoun A; Hotait M; Wazne J; Beydoun A
    Epilepsia; 2023 Aug; 64(8):2153-2161. PubMed ID: 37264785
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    Kanner AM; Ashman E; Gloss D; Harden C; Bourgeois B; Bautista JF; Abou-Khalil B; Burakgazi-Dalkilic E; Llanas Park E; Stern J; Hirtz D; Nespeca M; Gidal B; Faught E; French J
    Neurology; 2018 Jul; 91(2):74-81. PubMed ID: 29898971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.